GGrantIndex
← Search

NOVEL COMBINED TARGETED TREATMENTS FOR ANDROGEN DEPENDENT AND INDEPENDENT PROSTATE CANCER

$78,346FY2010Department of DefenseDOD

Health Research, Inc., Rockville MD

Investigators

View source on USAspending →
NOVEL COMBINED TARGETED TREATMENTS FOR ANDROGEN DEPENDENT AND INDEPENDENT PROSTATE CANCER · GrantIndex